2020-06-30·Nature Medicine (New York, NY, United States)
Kawasaki disease in a COVID-19-struck region
作者: Stower, Hannah
A review on Kawasaki disease in a COVID-19-struck region.
2020-04-30·Nature Medicine (New York, NY, United States)
Lopinavir-ritonavir in severe COVID-19
作者: Stower, Hannah
A randomized, controlled, open-label trial of lopinavir-ritonavir in patients with severe COViD-19 shows no benefit for the primary endpoint beyond standard care but shows benefit for some secondary endpoints.
2020-04-30·Nature Medicine (New York, NY, United States)
Functionally assessing coronavirus entry
作者: Stower, Hannah
Letko et al. have developed a rapid, cost effective screening platform for coronavirus entry into human cells that requires only the synthesis of the receptor-binding domain and have screened all published lineage B coronaviruses. They identify some lineage B coronaviruses that are able to enter human cells but find that some are challenged by the human protease. They confirm that SARSCoV-2 uses the human ACE2 receptor to enter cells.